Ovarian Cancer

The Pharmacy Times® Ovarian Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to the group of diseases that originates in the ovaries, fallopian tubes, or the peritoneum.

Latest News

Ovarian cancer -- Image credit: Lars Neumann | stock.adobe.com
CUSP06 Granted FDA Fast Track Designation for Patients With Platinum-Resistant Ovarian Cancer

February 13th 2025

Currently, the Cadherin-6 targeting antibody-drug conjugate is undergoing evaluation in a phase 1a/1b clinical trial.

Ovarian cancer, 3D illustration - Image credit: Dr_Microbe | stock.adobe.com
Avutometinib Plus Defactinib Moves One Step Closer to Approval for Treatment of Ovarian Cancer

January 6th 2025

Teal ribbon for ovarian cancer awareness -- Image credit: Queenmoonlite Studio | stock.adobe.com
Avutometinib With Defactinib for Recurrent KRAS Mutant LGSOC Completes Rolling New Drug Application

November 2nd 2024

Ovarian cancer -- Image credit: Lars Neumann | stock.adobe.com
FDA Grants Fast Track Designation to VLS-1488 For Patients With Platinum-Resistant HGSOC

October 2nd 2024

Image Credit: © motortion - stock.adobe.com
FDA Approves New Drug Application for Tepylute to Treat Breast, Ovarian Cancer

June 28th 2024

<12345